XML 15 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Nov. 30, 2025
Nov. 30, 2024
Nov. 30, 2025
Nov. 30, 2024
Statement of Comprehensive Income [Abstract]        
Net income available to common shareholders $ 41,075 $ 33,603 $ 301,329 $ 32,226
Other Comprehensive Income (Loss):        
Unrealized translation gain (loss) (1,033) (1,943) 1,131 (1,504)
Unrealized translation gain (loss) for unconsolidated subsidiary, net of tax (158) [1] (730) [1] 738 (1,261)
Unrealized gain (loss) on interest rate swap, net of tax 83 [2] 1,037 [2] (792) 194
Amounts reclassified from accumulated other comprehensive income to earnings, net of tax (215) [3] (663) [3] (505) (2,876)
Unrealized gain (loss) on interest rate swap, net of tax for unconsolidated subsidiary 0 [4] (188) [4] 11 (41)
Other comprehensive income (loss) (1,323) (2,487) 583 (5,488)
Comprehensive income $ 39,752 $ 31,116 $ 301,912 $ 26,738
[1]
Unrealized translation gain (loss) for unconsolidated subsidiary is related to our unconsolidated investment in the AVAIL JV and represents our 40% interest in this amount. Net of tax benefit of $(54) and ($227) for the three months ended November 30, 2025 and November 30, 2024, respectively. Net of tax expense (benefit) of $228 and ($438) for the nine months ended November 30, 2025 and November 30, 2024, respectively.
[2]
Net of tax expense of $31 and $327 for the three months ended November 30, 2025 and November 30, 2024, respectively. Net of tax benefit of ($240) and ($15) for the nine months ended November 30, 2025 and November 30, 2024, respectively.
[3]
Net of tax benefit of ($67) and ($209) for the three months ended November 30, 2025 and November 30, 2024, respectively. Net of tax benefit of ($160) and ($908) for the nine months ended November 30, 2025 and November 30, 2024, respectively. See Note 9.
[4]
Unrealized gain (loss) on interest rate swap, net of tax for unconsolidated subsidiary is related to our unconsolidated investment in the AVAIL JV and represents our 40% interest in this amount. Net of tax benefit of $0 and ($59) for the three months ended November 30, 2025 and November 30, 2024, respectively. Net of tax expense (benefit) of $5 and ($13) for the nine months ended November 30, 2025 and November 30, 2024, respectively.